As requested by the Federal Court, a reconstituted CRP considered again complaints 2011-11-001 and 2011-11-009 about a number of Swisse Products.
In a 71 page judgement published on 4 June 2013, twenty television advertisements were reviewed for the following products: Swisse Men’s Ultivite, Swisse Women’s Ultivite, Swisse Ultiboost Inner Balance, Swisse Ultiboost Sleep, Swisse Ultiboost Hair Skin and Nails, Swisse Ultiboost Liver Detox, a Prevention Pack, Swisse Ultiboost Wild Krill Oil, Swisse Ultiboost Coenzyme Q10, Swisse Ultiboost Glucosamine and Swisse Ultiboost Chlorophyll.
It was determined that the following provisions of the Therapeutic Goods Advertising Code had been breached: sections 4(1)(b), 4(2)(a), 4(2)(c) in all advertisements except Nos. 6, 7, 10 and 11; 4(1)(b), 4(2)(c) in No. 7; 4(4) in No. 2 (also 13); 4(5) in No.5; 4(2)(d) in Nos. 18 and 19; also the Therapeutic Goods Act Act section 22(5) in No. 8.
The CRP requested Swisse to withdraw the advertisements and representations that breached the Code and Act.
In response Swisse Wellness chief executive Radek Sali deemed the ruling “ridiculous” and accused the panel of being “unqualified” to evaluate the evidence Swisse presented to support the health claims and called for an immediate overhaul of the panel.by